Table 5. Comparative study of the results of present study with others.
AUB: Abnormal uterine bleeding; DPE: Disordered proliferative endometrium; EM: Endometrium; Hyp: Hyperplasia
| Present study | Doraiswami et al. [10] | Mune et al. [11] | Desai et al. [12] | Vijayaraghavan et al. [13] | |
| Total no. of cases | 850 | 409 | 212 | 98 | 160 |
| Type of bleeding | AUB | AUB | AUB | AUB | AUB |
| Most common age group | 41-50 (44.5%) | 41-50 (33.5%) | 41-50 (42.0%) | 41-50 (42.85%) | 41-50 (56.3%) |
| Functional causes | 628 (73.9%) | - | 137 (64.6%) | 62 (63.25%) | 104 (65.0%) |
| Organic lesions | 222 (26.1%) | - | 75 (35.4%) | 36 (36.75%) | 56 (35.0%) |
| Common histopathologic diagnosis | DPE (27.7%) | DPE (20.53%) | DPE (13.7%) | DPE (19.38%) | DPE (7.5%) |
| Proliferative pattern (18.2%) | - | Proliferative pattern (27.8%) | Proliferative pattern (20.4%) | Proliferative pattern (35%) | |
| EM Polyp (12%) | EM Polyp (11.24%) | EM Polyp (8.0%) | EM Polyp (8.16%) | EM Polyp (4.4%) | |
| Atrophic EM (4.0%) | Atrophic EM (2.4%) | Atrophic EM (2.4%) | Atrophic EM (3.1%) | Atrophic EM (0.97%) | |
| Chronic endometritis (0.0%) | Chronic endometritis (4.1%) | Chronic endometritis (2.4%) | Chronic endometritis (1.03%) | Chronic endometritis (5.36%) | |
| Frequency of hyperplasia | Non-atypical hyp (6.5%) | Non-atypical hyp (4.16%) | Non-atypical hyp (20.3%) | Non-atypical hyp (15.3%) | Non-atypical hyp (20.6%) |
| Atypical hyp (4.8%) | Atypical hyp (2.0%) | Atypical hyp (2.0%) | Atypical hyp (6.12%) | Atypical hyp (5.6%) | |
| Frequency of malignancy | Carcinoma (2.6%) | Carcinoma (4.4%) | Carcinoma (2.3%) | Carcinoma (5.1%) | Carcinoma (1.25%) |